Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Poupon

Showing results (241-250 of 263) with videos related to

Pageof 27
Sort By:
Journal of Hepatology|July 25, 2000
Cold preservation injury in rat liver: effect of liposomally-entrapped adenosine triphosphateN Neveux, J P De Bandt, E Fattal, et al.
Journal of Hepatology|July 1, 1990
Ursodeoxycholic acid for primary sclerosing cholangitisO Chazouillères, R Poupon, J P Capron, et al.
Hepatology (Baltimore, Md.)|November 26, 1999
Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epitheliumF Lakehal, D Wendum, V Barbu, et al.
Transplantation Proceedings|October 1, 1990
HLA class I matching is responsible for the hepatic lesions in recurrent viral hepatitis B after liver transplantationY Calmus, L Hannoun, B Dousset, et al.
Journal of Hepatology|November 1, 1992
Tumor necrosis factor-alpha in liver transplantation and resection. No evidence for a key role in ischemia-reperfusion injuryO Chazouillères, J Guéchot, P Balladur, et al.
The Journal of Clinical Investigation|June 24, 1998
Endothelin-1 is synthesized and inhibits cyclic adenosine monophosphate- dependent anion secretion by an autocrine/paracrine mechanism in gallbladder epithelial cellsL Fouassier, T Chinet, B Robert, et al.
AIDS (London, England)|October 16, 2001
Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control studyL Serfaty, D Costagliola, D Wendum, et al.
Hepatology (Baltimore, Md.)|May 1, 1984
A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final reportD Lebrec, T Poynard, J Bernuau, et al.
Drugs|January 1, 1989
A randomised controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosisD Lebrec, T Poynard, J Bernuau, et al.
Journal of Hepatology|January 1, 1991
Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing studyC Trépo, P Rougier, T Bizollon, et al.
Pageof 27

Showing results (241-250 of 263) with videos related to

Sort By:
Pageof 27
Journal of Hepatology|July 25, 2000
Cold preservation injury in rat liver: effect of liposomally-entrapped adenosine triphosphateN Neveux, J P De Bandt, E Fattal, et al.
Journal of Hepatology|July 1, 1990
Ursodeoxycholic acid for primary sclerosing cholangitisO Chazouillères, R Poupon, J P Capron, et al.
Hepatology (Baltimore, Md.)|November 26, 1999
Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epitheliumF Lakehal, D Wendum, V Barbu, et al.
Transplantation Proceedings|October 1, 1990
HLA class I matching is responsible for the hepatic lesions in recurrent viral hepatitis B after liver transplantationY Calmus, L Hannoun, B Dousset, et al.
Journal of Hepatology|November 1, 1992
Tumor necrosis factor-alpha in liver transplantation and resection. No evidence for a key role in ischemia-reperfusion injuryO Chazouillères, J Guéchot, P Balladur, et al.
The Journal of Clinical Investigation|June 24, 1998
Endothelin-1 is synthesized and inhibits cyclic adenosine monophosphate- dependent anion secretion by an autocrine/paracrine mechanism in gallbladder epithelial cellsL Fouassier, T Chinet, B Robert, et al.
AIDS (London, England)|October 16, 2001
Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control studyL Serfaty, D Costagliola, D Wendum, et al.
Hepatology (Baltimore, Md.)|May 1, 1984
A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final reportD Lebrec, T Poynard, J Bernuau, et al.
Drugs|January 1, 1989
A randomised controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosisD Lebrec, T Poynard, J Bernuau, et al.
Journal of Hepatology|January 1, 1991
Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing studyC Trépo, P Rougier, T Bizollon, et al.
Pageof 27